| 1 |
10810178 | Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation. | 2000 Apr |
3 |
| 2 |
10915472 | Pharmacological effect of nitroprusside on platelet aggregation. | 1999 Dec |
1 |
| 3 |
1514698 | The human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor. | 1992 Jul |
1 |
| 4 |
1526066 | Xanthines inhibit human platelet aggregation induced by platelet-activating factor. | 1992 Aug |
4 |
| 5 |
1902328 | Nitroprusside in vitro inhibits platelet aggregation and intracellular calcium translocation. Effect of haemoglobin. | 1991 Jan 15 |
1 |
| 6 |
2557776 | Effects of ethanol on human platelets stimulated with platelet-activating factor, a biologically active ether phospholipid. | 1989 Dec |
1 |
| 7 |
2783040 | The detection of platelet-activating factor in inflamed human gingival tissue. | 1989 |
1 |
| 8 |
2963184 | Endogenous platelet-activating factor and anti-platelet-activating factor in patients with renovascular hypertension. | 1988 |
1 |
| 9 |
2977405 | Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension. | 1988 Aug |
1 |
| 10 |
3183958 | Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412. | 1988 Nov |
1 |
| 11 |
2961218 | At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation. | 1987 Oct |
1 |
| 12 |
3587377 | Triazolodiazepines are potent antagonists of platelet activating factor (PAF) in vitro and in vivo. | 1987 Mar |
1 |
| 13 |
3706054 | Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin. | 1986 Mar |
8 |
| 14 |
2934863 | Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway. | 1985 Nov 1 |
3 |
| 15 |
3832867 | In vivo arterial platelet-vessel wall interaction and thrombosis: induction, on-line registration and ultrastructural control. | 1985 |
1 |
| 16 |
3991494 | Direct interaction between polymorphonuclear neutrophils and cuprophan membranes in a plasma-free model of dialysis. | 1985 |
1 |
| 17 |
6091666 | Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. | 1984 Oct 1 |
2 |
| 18 |
6431801 | Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects. | 1984 Aug |
2 |
| 19 |
6408754 | Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor. | 1983 Apr 15 |
3 |
| 20 |
6858789 | Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. | 1983 Feb |
1 |
| 21 |
7450901 | Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation. | 1981 |
1 |